Skip to main content
. 2012 Jan 1;6(1):5–14. doi: 10.1177/193229681200600102

Table 6.

Percentage of Patients with and without Glucocorticoid Use by Glucose Cutoffa

n <65 mg/dlbn (%) >110 mg/dl n (%) >140 mg/dl n (%) >180 mg/dl n (%) >200 mg/dl n (%)
Dexamethasone 293 82 (28.0) 203 (69.3) 146 (49.8) 92 (31.4) 69 (23.5)
No dexamethasone 880 107 (12.2) 269 (30.6) 133 (15.1) 72 (8.2) 54 (6.1)

Methylprednisolone 191 37 (19.4)c 104 (54.5) 71 (37.2) 48 (25.1) 38 (19.9)
No methylprednisolone 982 152 (15.5)c 368 (37.5) 208 (21.2) 116 (11.8) 85 (8.7)

Prednisone 182 20 (11.0)c 84 (46.2)c 51 (28.0)c 30 (16.5)c 21 (11.5)c
No prednisone 991 169 (17.1)c 388 (39.2)c 228 (23.0)c 134 (13.5)c 102 (10.3)c

Hydrocortisone 39 29 (74.4) 35 (89.7) 26 (66.7) 23 (59.0) 18 (46.2)
No hydrocortisone 1134 160 (14.1) 437 (38.5) 253 (22.3) 141 (12.4) 105 (9.3)

Any glucocorticoid 505 117 (23.2) 309 (61.2) 210 (41.6) 133 (26.3) 99 (19.6)
None 668 72 (10.8) 163 (24.4) 69 (10.3) 31 (4.6) 24 (3.6)
a

In patients with three or more blood glucose measurements obtained at each cutoff. All p values < 0.001, except where indicated.

b

Patients with one or more values <65 mg/dl.

c

p value > 0.05.